High heterogeneity on the accepted vaccines for COVID-19 certificates in European countries. Issue 48 (July 2022)
- Record Type:
- Journal Article
- Title:
- High heterogeneity on the accepted vaccines for COVID-19 certificates in European countries. Issue 48 (July 2022)
- Main Title:
- High heterogeneity on the accepted vaccines for COVID-19 certificates in European countries
- Authors:
- Dal-Ré, Rafael
Banzi, Rita
Becker, Sören L.
Launay, Odile
Pavli, Androula - Abstract:
- Abstract: Background: We aimed to elucidate which vaccines were accepted by European countries as valid proof of vaccination against COVID-19 for international travelers. Method: On 27-September-2021 a cross-sectional study was conducted on VisaGuide.World, that reports on valid vaccines for international travelers. Other databases, lay press and regulatory agencies were also checked. The main outcome measure was which of the vaccines included on the WHO emergency use listing (EUL) [ChAdOx1 (Vaxzevria, Covishield), BNT162b2, mRNA-1273, Ad26.CoV2.S, BBIBP-CorV, CoronaVac] and Sputnik V, were accepted in each country. The influence of the vaccines approved for COVID-19 vaccination programs on the vaccines recognized as proof of vaccination was assessed. Results: There was a remarkable heterogeneity on the vaccines accepted as proof of vaccination among 46 countries. Russia accepted only one. Cyprus, Greece and Slovenia accepted all vaccines considered. Eleven countries accepted the seven WHO EUL vaccines: eight EU countries, plus Iceland, Norway and Switzerland. Seven EU countries accepted only the four EMA-authorized vaccines. Considering Covishield as equivalent to Vaxzevria, 69% of countries recognized only vaccinated travelers who received any of the vaccines approved for vaccination programs in the country of arrival as valid. Conclusion: Vaccines accepted as proof of vaccination should be harmonized. Accepting any of the WHO EUL vaccines would be a scientifically soundAbstract: Background: We aimed to elucidate which vaccines were accepted by European countries as valid proof of vaccination against COVID-19 for international travelers. Method: On 27-September-2021 a cross-sectional study was conducted on VisaGuide.World, that reports on valid vaccines for international travelers. Other databases, lay press and regulatory agencies were also checked. The main outcome measure was which of the vaccines included on the WHO emergency use listing (EUL) [ChAdOx1 (Vaxzevria, Covishield), BNT162b2, mRNA-1273, Ad26.CoV2.S, BBIBP-CorV, CoronaVac] and Sputnik V, were accepted in each country. The influence of the vaccines approved for COVID-19 vaccination programs on the vaccines recognized as proof of vaccination was assessed. Results: There was a remarkable heterogeneity on the vaccines accepted as proof of vaccination among 46 countries. Russia accepted only one. Cyprus, Greece and Slovenia accepted all vaccines considered. Eleven countries accepted the seven WHO EUL vaccines: eight EU countries, plus Iceland, Norway and Switzerland. Seven EU countries accepted only the four EMA-authorized vaccines. Considering Covishield as equivalent to Vaxzevria, 69% of countries recognized only vaccinated travelers who received any of the vaccines approved for vaccination programs in the country of arrival as valid. Conclusion: Vaccines accepted as proof of vaccination should be harmonized. Accepting any of the WHO EUL vaccines would be a scientifically sound objective. … (more)
- Is Part Of:
- Travel medicine and infectious disease. Issue 48(2022)
- Journal:
- Travel medicine and infectious disease
- Issue:
- Issue 48(2022)
- Issue Display:
- Volume 48, Issue 48 (2022)
- Year:
- 2022
- Volume:
- 48
- Issue:
- 48
- Issue Sort Value:
- 2022-0048-0048-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-07
- Subjects:
- COVID-19 -- Passports -- Certificates -- Europe -- Vaccination -- Travel
Travel -- Health aspects -- Periodicals
Communicable diseases -- Periodicals
Tropical medicine -- Periodicals
610.5 - Journal URLs:
- http://www.sciencedirect.com/science/journal/14778939 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.tmaid.2022.102321 ↗
- Languages:
- English
- ISSNs:
- 1477-8939
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9045.452675
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21799.xml